Comparative Analysis of Nvidia and AMD Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy NVDA?
Source: Fool
- Company Overview: Nvidia and AMD are two of the world's leading semiconductor companies, each significantly impacting the graphics processing and computing sectors, drawing considerable investor interest.
- Stock Performance: As of the afternoon of April 4, 2026, Nvidia's stock price increased by 0.07%, while AMD's stock price rose by 0.45%, indicating AMD's relatively stronger performance in the short term.
- Market Competition: The two companies are engaged in fierce competition regarding technological innovation and market share, necessitating careful evaluation of their respective growth potentials and risks by investors.
- Investment Recommendation: While both companies present investment value, selecting the stock with greater potential in the current market environment will significantly impact investor returns.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NVDA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NVDA
Wall Street analysts forecast NVDA stock price to rise
41 Analyst Rating
39 Buy
1 Hold
1 Sell
Strong Buy
Current: 178.100
Low
200.00
Averages
264.97
High
352.00
Current: 178.100
Low
200.00
Averages
264.97
High
352.00
About NVDA
NVIDIA Corporation is an artificial intelligence (AI) infrastructure company. The Company is engaged in accelerated computing to help solve the challenging computational problems. Its segments include Compute & Networking and Graphics. The Compute & Networking segment includes its Data Center accelerated computing and networking platforms and AI solutions and software, and automotive platforms and autonomous and electric vehicle solutions, including software. The Graphics segment includes GeForce GPUs for gaming and personal computers (PCs), and Quadro/NVIDIA RTX GPUs for enterprise workstation graphics. Its technology stack includes the foundational NVIDIA CUDA development platform that runs on all NVIDIA GPUs, as well as hundreds of domain-specific software libraries, frameworks, algorithms, software development kits (SDKs), and application programming interfaces (APIs). Its platforms address four markets, which include Data Center, Gaming, Professional Visualization, and Automotive.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
OpenAI Pauses Stargate Project in the UK Due to Regulatory and Energy Costs
- Project Pause Reasons: OpenAI has announced the pause of its Stargate project in the UK due to regulatory and energy cost concerns, which were initially set to deploy up to 8,000 GPUs in partnership with Nvidia and Nscale, highlighting the challenges posed by the current market environment for large infrastructure investments.
- Future Exploration Plans: Despite the pause, OpenAI stated it will continue to explore the Stargate project and plans to restart when appropriate regulatory conditions and lower energy costs are in place, indicating the company's confidence in the UK's AI future and its long-term investment intentions.
- Talent Investment and Local Expansion: During the project pause, OpenAI is still investing in talent and expanding its local presence in the UK, aiming to support the government's commitment to adopting frontier AI in public services, demonstrating the company's ongoing commitment to the market.
- Industry Potential Outlook: An OpenAI spokesperson emphasized that despite the challenges, they remain optimistic about the UK's AI future, with London being home to their largest international research hub, indicating the company's continued dedication to helping the UK achieve its goal of becoming an AI leader.
See More
Firmus Technologies Secures $505 Million Funding Round to Expand AI Infrastructure
- Significant Funding: Firmus Technologies has successfully secured a $505 million funding round, valuing the company at $5.5 billion, indicating strong investor interest in compute capacity tied to AI demand, which will further drive infrastructure development in the Asia-Pacific region.
- Clear Use of Funds: The newly raised capital is earmarked for the rapid deployment of AI infrastructure built on Nvidia's upcoming generation of computing systems, which is expected to significantly enhance Firmus's competitiveness in the data center market to meet the growing AI compute demand.
- Renewable Energy Initiative: The Southgate initiative in Australia will utilize renewable energy and initially deploy 36,000 Nvidia accelerator chips, demonstrating the company's commitment to sustainability while attracting attention from global hyperscaler customers, suggesting future market demand visibility.
- Deepening Strategic Partnerships: Nvidia's participation in this funding round reinforces its strategy of supporting ecosystem expansion, and despite scrutiny over its business model, the company continues to show a willingness to invest in AI infrastructure, reflecting the trend of capital moving across the full AI value chain.
See More
CoreWeave Expands $21 Billion Deal with Meta Platforms
- Stock Surge: CoreWeave Inc. shares surged over 8% in Thursday's pre-market trading, reflecting strong market sentiment following the announcement of an expanded $21 billion deal with Meta Platforms Inc., indicating investor confidence in the company's growth potential.
- Long-Term Partnership: In a joint announcement, CoreWeave stated it will provide AI cloud capacity to Meta through December 2032, underscoring the company's significant role and ongoing business expansion in the rapidly growing AI market.
- Multi-Site Deployment: CoreWeave will allocate capacity across multiple locations, including initial deployments of Nvidia Corp.'s Vera Rubin platform, which enhances its competitive edge in technological infrastructure while meeting Meta's demand for high-performance computing.
- Market Sentiment Analysis: Although retail sentiment on Stocktwits for CoreWeave trended in the 'neutral' territory, the stock was the second most trending ticker on the platform, indicating market attention and potential investment opportunities for its future performance.
See More
Moderna and Target Stocks Show Recovery
- Moderna Stock Surge: Since the beginning of the year, Moderna's stock has surged nearly 70%, driven by the launch of new vaccine products and a focus on seasonal vaccines, with expectations of up to 10% revenue growth this year, indicating a recovery that is attracting investor interest.
- Vaccine Revenue Support: After generating over $18 billion in vaccine revenue in 2022, Moderna is reshaping its revenue structure by introducing new COVID-19 and RSV vaccines, with seasonal vaccines expected to drive the development of other programs.
- Target's Strategic Transformation: Target's stock has risen over 20% since the start of the year, thanks to a $200 million investment plan by new CEO Michael Fiddelke aimed at improving product displays, refreshing the product assortment, and enhancing employee training to boost customer experience and sales growth.
- Competitive Advantage Enhancement: Despite pressure from competitors like Walmart, Target's lower forward P/E ratio of 14x compared to peers indicates greater growth potential, suggesting that its recovery story in the retail market is ongoing and attracting investor attention.
See More
Investors Shift Focus to Healthcare and Retail Stocks
- Market Shift: In an uncertain market, investors are turning to healthcare and retail stocks, perceived as 'safer' investments due to their potential for revenue stability, reflecting concerns over slowing economic growth.
- Moderna's Recovery: Moderna generated over $18 billion from its COVID-19 vaccine during the pandemic's early days, but its stock plummeted 90% as demand waned; however, investors are now returning, anticipating up to 10% revenue growth in 2023 as it focuses on seasonal vaccines, oncology, and rare diseases.
- Target's Transformation: Target benefited from digital initiatives during the pandemic but faced challenges afterward; new CEO Michael Fiddelke has launched a multi-year $2 billion investment plan to enhance product displays and employee training, resulting in a stock price increase of over 20% since the start of the year.
- Investment Opportunities: With increasing market interest in healthcare and retail stocks, the recovery narratives of Moderna and Target are attracting investors, particularly as Target's price-to-earnings ratio stands at just 14 times, significantly lower than its competitors, indicating substantial growth potential ahead.
See More
Major Moves in Premarket Trading by Various Companies
- Datadog Stock Rise: Datadog shares increased by 2.3% after Guggenheim upgraded its rating from neutral to buy, with analysts believing the company will benefit from AI-driven growth in data volumes and IT complexity.
- CoreWeave Infrastructure Expansion: CoreWeave's stock surged over 5% following the announcement of a $21 billion infrastructure deal with Meta Platforms, which aims to optimize performance and scalability for Meta's AI operations.
- Constellation Brands Guidance Withdrawal: Constellation Brands saw its shares dip less than 1% after withdrawing its 2028 guidance due to subdued demand, despite reporting fourth-quarter results that exceeded market expectations.
- Airlines Stock Fluctuation: Rising oil prices led to a decline in airline stocks, with Alaska Air dropping approximately 2%, while United Airlines, American Airlines, and Delta Air Lines each fell by 1%.
See More
OpenAI Pauses Stargate Project in the UK Due to Regulatory and Energy Costs
- Project Pause Reasons: OpenAI has announced the pause of its Stargate project in the UK due to regulatory and energy cost concerns, which were initially set to deploy up to 8,000 GPUs in partnership with Nvidia and Nscale, highlighting the challenges posed by the current market environment for large infrastructure investments.
- Future Exploration Plans: Despite the pause, OpenAI stated it will continue to explore the Stargate project and plans to restart when appropriate regulatory conditions and lower energy costs are in place, indicating the company's confidence in the UK's AI future and its long-term investment intentions.
- Talent Investment and Local Expansion: During the project pause, OpenAI is still investing in talent and expanding its local presence in the UK, aiming to support the government's commitment to adopting frontier AI in public services, demonstrating the company's ongoing commitment to the market.
- Industry Potential Outlook: An OpenAI spokesperson emphasized that despite the challenges, they remain optimistic about the UK's AI future, with London being home to their largest international research hub, indicating the company's continued dedication to helping the UK achieve its goal of becoming an AI leader.
See More
Firmus Technologies Secures $505 Million Funding Round to Expand AI Infrastructure
- Significant Funding: Firmus Technologies has successfully secured a $505 million funding round, valuing the company at $5.5 billion, indicating strong investor interest in compute capacity tied to AI demand, which will further drive infrastructure development in the Asia-Pacific region.
- Clear Use of Funds: The newly raised capital is earmarked for the rapid deployment of AI infrastructure built on Nvidia's upcoming generation of computing systems, which is expected to significantly enhance Firmus's competitiveness in the data center market to meet the growing AI compute demand.
- Renewable Energy Initiative: The Southgate initiative in Australia will utilize renewable energy and initially deploy 36,000 Nvidia accelerator chips, demonstrating the company's commitment to sustainability while attracting attention from global hyperscaler customers, suggesting future market demand visibility.
- Deepening Strategic Partnerships: Nvidia's participation in this funding round reinforces its strategy of supporting ecosystem expansion, and despite scrutiny over its business model, the company continues to show a willingness to invest in AI infrastructure, reflecting the trend of capital moving across the full AI value chain.
See More
CoreWeave Expands $21 Billion Deal with Meta Platforms
- Stock Surge: CoreWeave Inc. shares surged over 8% in Thursday's pre-market trading, reflecting strong market sentiment following the announcement of an expanded $21 billion deal with Meta Platforms Inc., indicating investor confidence in the company's growth potential.
- Long-Term Partnership: In a joint announcement, CoreWeave stated it will provide AI cloud capacity to Meta through December 2032, underscoring the company's significant role and ongoing business expansion in the rapidly growing AI market.
- Multi-Site Deployment: CoreWeave will allocate capacity across multiple locations, including initial deployments of Nvidia Corp.'s Vera Rubin platform, which enhances its competitive edge in technological infrastructure while meeting Meta's demand for high-performance computing.
- Market Sentiment Analysis: Although retail sentiment on Stocktwits for CoreWeave trended in the 'neutral' territory, the stock was the second most trending ticker on the platform, indicating market attention and potential investment opportunities for its future performance.
See More
Moderna and Target Stocks Show Recovery
- Moderna Stock Surge: Since the beginning of the year, Moderna's stock has surged nearly 70%, driven by the launch of new vaccine products and a focus on seasonal vaccines, with expectations of up to 10% revenue growth this year, indicating a recovery that is attracting investor interest.
- Vaccine Revenue Support: After generating over $18 billion in vaccine revenue in 2022, Moderna is reshaping its revenue structure by introducing new COVID-19 and RSV vaccines, with seasonal vaccines expected to drive the development of other programs.
- Target's Strategic Transformation: Target's stock has risen over 20% since the start of the year, thanks to a $200 million investment plan by new CEO Michael Fiddelke aimed at improving product displays, refreshing the product assortment, and enhancing employee training to boost customer experience and sales growth.
- Competitive Advantage Enhancement: Despite pressure from competitors like Walmart, Target's lower forward P/E ratio of 14x compared to peers indicates greater growth potential, suggesting that its recovery story in the retail market is ongoing and attracting investor attention.
See More
Investors Shift Focus to Healthcare and Retail Stocks
- Market Shift: In an uncertain market, investors are turning to healthcare and retail stocks, perceived as 'safer' investments due to their potential for revenue stability, reflecting concerns over slowing economic growth.
- Moderna's Recovery: Moderna generated over $18 billion from its COVID-19 vaccine during the pandemic's early days, but its stock plummeted 90% as demand waned; however, investors are now returning, anticipating up to 10% revenue growth in 2023 as it focuses on seasonal vaccines, oncology, and rare diseases.
- Target's Transformation: Target benefited from digital initiatives during the pandemic but faced challenges afterward; new CEO Michael Fiddelke has launched a multi-year $2 billion investment plan to enhance product displays and employee training, resulting in a stock price increase of over 20% since the start of the year.
- Investment Opportunities: With increasing market interest in healthcare and retail stocks, the recovery narratives of Moderna and Target are attracting investors, particularly as Target's price-to-earnings ratio stands at just 14 times, significantly lower than its competitors, indicating substantial growth potential ahead.
See More
Major Moves in Premarket Trading by Various Companies
- Datadog Stock Rise: Datadog shares increased by 2.3% after Guggenheim upgraded its rating from neutral to buy, with analysts believing the company will benefit from AI-driven growth in data volumes and IT complexity.
- CoreWeave Infrastructure Expansion: CoreWeave's stock surged over 5% following the announcement of a $21 billion infrastructure deal with Meta Platforms, which aims to optimize performance and scalability for Meta's AI operations.
- Constellation Brands Guidance Withdrawal: Constellation Brands saw its shares dip less than 1% after withdrawing its 2028 guidance due to subdued demand, despite reporting fourth-quarter results that exceeded market expectations.
- Airlines Stock Fluctuation: Rising oil prices led to a decline in airline stocks, with Alaska Air dropping approximately 2%, while United Airlines, American Airlines, and Delta Air Lines each fell by 1%.
See More
